These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1426 related items for PubMed ID: 22452685
1. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema. Sheth S, Rush R, Natarajan S, Gillies M. Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685 [Abstract] [Full Text] [Related]
3. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R. Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109 [Abstract] [Full Text] [Related]
4. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study. Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M. Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098 [Abstract] [Full Text] [Related]
5. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema. Liu Q, Hu Y, Yu H, Yuan L, Hu J, Atik A, Guan M, Li D, Li X, Tang S. Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313 [Abstract] [Full Text] [Related]
6. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA. Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585 [Abstract] [Full Text] [Related]
7. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K. Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456 [Abstract] [Full Text] [Related]
11. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Lim JW, Lee HK, Shin MC. Ophthalmologica; 2012 May; 227(2):100-6. PubMed ID: 21997197 [Abstract] [Full Text] [Related]
12. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA. Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244 [Abstract] [Full Text] [Related]
13. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA. Retina; 2007 Feb; 27(9):1187-95. PubMed ID: 18046223 [Abstract] [Full Text] [Related]
14. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results. Lim LL, Morrison JL, Constantinou M, Rogers S, Sandhu SS, Wickremasinghe SS, Kawasaki R, Al-Qureshi S. Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700 [Abstract] [Full Text] [Related]
15. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY. Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW. Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346 [Abstract] [Full Text] [Related]
16. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Cheng KC, Wu WC, Chen KJ. Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117 [Abstract] [Full Text] [Related]
17. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Wu WC, Cheng KC, Wu HJ. Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991 [Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results. Kriechbaum K, Prager S, Mylonas G, Scholda C, Rainer G, Funk M, Kundi M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group. Eye (Lond); 2014 Jan; 28(1):9-15; quiz 16. PubMed ID: 24336297 [Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. Wang YS, Li X, Wang HY, Zhang ZF, Li MH, Su XN. Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332 [Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Faghihi H, Roohipoor R, Mohammadi SF, Hojat-Jalali K, Mirshahi A, Lashay A, Piri N, Faghihi Sh. Eur J Ophthalmol; 2008 Feb; 18(6):941-8. PubMed ID: 18988166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]